Driehaus Small/Mid Cap Growth Fund's Driehaus Small/Mid Cap Growth Fund (DSMDX) has disclosed 107 total holdings in their latest N-PORT filing with the SEC for the
portfolio date of 2024-09-30. The current portfolio value is calculated to be $57.00 Mil, only including common equities, preferred
equities, ETFs, options and warrants for equities. The turnover rate is 32%.
Driehaus Small/Mid Cap Growth Fund (DSMDX)'s
Total Assets is $56.99 Mil , Total Liabilities is $64,140.00 , Net Assets is $56.93 Mil.
In Driehaus Small/Mid Cap Growth Fund (DSMDX)'s current portfolio as of 2024-09-30, the top 5 holdings are
Axon Enterprise Inc (AXON), Vaxcyte Inc (PCVX), Crinetics Pharmaceuticals Inc (CRNX), TransMedics Group Inc (TMDX) and Heico Corp (HEI),
not including call and put options.
Driehaus Small/Mid Cap Growth Fund (DSMDX) did not buy any new stocks in the current portfolio.
Please visit the "Current Portfolio" tab to see the mutual fund's current and past N-PORT holdings for Driehaus Small/Mid Cap Growth Fund (DSMDX), as well as holding map,
valuations for each stock, which positions are undervalued, have low PE Ratios, are considered high quality and recently traded at 52-week lows, etc.
Please visit the "Stock Picks" tab to see the mutual fund's latest trades and stock picks for Driehaus Small/Mid Cap Growth Fund (DSMDX), which include data from form N-PORT.
Please visit the "Summary" page to see the top 10 holdings, recent stock picks, performance, sector / industry breakdown details, as well as past holding history summary for Driehaus Small/Mid Cap Growth Fund.